Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells.

MLA

Hu, Wei-Bin, et al. “Pristimerin Exhibits Anti-Cancer Activity by Inducing ER Stress and AKT/GSK3β Pathway through Increasing Intracellular ROS Production in Human Esophageal Cancer Cells.” Toxicology in Vitro : An International Journal Published in Association with BIBRA, vol. 99, Aug. 2024, p. 105867. EBSCOhost, https://doi.org/10.1016/j.tiv.2024.105867.

APA

Hu, W.-B., Liu, Y.-T., Li, J., Wang, Y., Sun, X.-Z., Hua, M.-Y., Liu, X.-T., & Hui, B.-N. (2024). Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells. Toxicology in Vitro : An International Journal Published in Association with BIBRA, 99, 105867. https://doi.org/10.1016/j.tiv.2024.105867

Chicago

Hu, Wei-Bin, Yi-Ting Liu, Jing Li, Ying Wang, Xuan-Zi Sun, Ming-Yu Hua, Xue-Ting Liu, and Bei-Na Hui. 2024. “Pristimerin Exhibits Anti-Cancer Activity by Inducing ER Stress and AKT/GSK3β Pathway through Increasing Intracellular ROS Production in Human Esophageal Cancer Cells.” Toxicology in Vitro : An International Journal Published in Association with BIBRA 99 (August): 105867. doi:10.1016/j.tiv.2024.105867.